Quarterly report · Q3
4272.TEDINET S100Q44W
Period2022-04-01 → 2022-12-31
Filed2023-02-08
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥153.6bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥184.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥138.1bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥19.1bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥17.3bn | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥21.0bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥23.2bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥18.8bn | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥21.6bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥19.9bn | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥15.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥17.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥14.1bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥15.3bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥14.1bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥331.4bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥315.5bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥309.6bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥75.7bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥69.0bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥255.7bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥246.4bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥238.0bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥41.5bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥38.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥90.62 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.57 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥101.7 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥83.1 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.85 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥90.6 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥101.65 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥83.09 | 2021-04-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 76.9% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.8% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.6% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 52
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-12-31 | ¥8.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥7.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥82m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-12-31 | ¥1.5bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥204m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥204m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥5.7bn |
| jpcrp040300-q3r_E00836-000Functional Chemicalsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥65.6bn |
| jpcrp040300-q3r_E00836-000Functional Chemicalsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥65.4bn |
| jpcrp040300-q3r_E00836-000Functional Chemicalsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥122m |
| jpcrp040300-q3r_E00836-000Functional Chemicalsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥10.1bn |
| jpcrp040300-q3r_E00836-000Medicinereportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥39.3bn |
| jpcrp040300-q3r_E00836-000Medicinereportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥39.3bn |
| jpcrp040300-q3r_E00836-000Medicinereportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥0 |
| jpcrp040300-q3r_E00836-000Medicinereportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥6.9bn |
| jpcrp040300-q3r_E00836-000Safety Systemsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥41.0bn |
| jpcrp040300-q3r_E00836-000Safety Systemsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥41.0bn |
| jpcrp040300-q3r_E00836-000Safety Systemsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥6.2bn |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥145.8bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥145.7bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥122m |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥23.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥153.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥153.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥204m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥24.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-12-31 | ¥6.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-12-31 | ¥6.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥78m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-12-31 | ¥1.4bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | −¥184m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-12-31 | −¥184m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-12-31 | −¥5.2bn |
| jpcrp040300-q3r_E00836-000Functional Chemicalsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥58.7bn |
| jpcrp040300-q3r_E00836-000Functional Chemicalsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥58.5bn |
| jpcrp040300-q3r_E00836-000Functional Chemicalsreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥106m |
| jpcrp040300-q3r_E00836-000Functional Chemicalsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥9.5bn |
| jpcrp040300-q3r_E00836-000Medicinereportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥39.7bn |
| jpcrp040300-q3r_E00836-000Medicinereportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥39.7bn |
| jpcrp040300-q3r_E00836-000Medicinereportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥0 |
| jpcrp040300-q3r_E00836-000Medicinereportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥6.9bn |
| jpcrp040300-q3r_E00836-000Safety Systemsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥33.3bn |
| jpcrp040300-q3r_E00836-000Safety Systemsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥33.3bn |
| jpcrp040300-q3r_E00836-000Safety Systemsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥4.7bn |
| —segment total | revenue | 2021-04-01 → 2021-12-31 | ¥131.7bn |
| —segment total | revenue external | 2021-04-01 → 2021-12-31 | ¥131.6bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥106m |
| —segment total | segment profit | 2021-04-01 → 2021-12-31 | ¥21.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-12-31 | ¥138.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-12-31 | ¥138.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥184m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-12-31 | ¥22.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 399
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 2165000 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0127 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row2Member | 18000 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row2Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row2Member | 18000 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row2Member | 0.0001 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row3Member | 10000 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row3Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row3Member | 10000 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row3Member | 0.0001 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 2193000 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 2193000 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0129 | |
| Cash and deposits | Prior1YearInstant | 38459000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 41514000000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 60719000000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | 64350000000 | JPY |
| Electronically recorded monetary claims operating ca | Prior1YearInstant | 1868000000 | JPY |
| Electronically recorded monetary claims operating ca | CurrentQuarterInstant | 2469000000 | JPY |
| Short term investment securities | Prior1YearInstant | 15186000000 | JPY |
| Short term investment securities | CurrentQuarterInstant | 6220000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 36784000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 44146000000 | JPY |
| Work in process | Prior1YearInstant | 1149000000 | JPY |
| Work in process | CurrentQuarterInstant | 950000000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 17901000000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 26012000000 | JPY |
| Other ca | Prior1YearInstant | 3832000000 | JPY |
| Other ca | CurrentQuarterInstant | 4946000000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -57000000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -54000000 | JPY |
| Current assets | Prior1YearInstant | 175843000000 | JPY |
| Current assets | CurrentQuarterInstant | 190556000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 43469000000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 43716000000 | JPY |
| Machinery equipment and vehicles net | Prior1YearInstant | 26923000000 | JPY |
| Machinery equipment and vehicles net | CurrentQuarterInstant | 26221000000 | JPY |
| Other net ppe | Prior1YearInstant | 18667000000 | JPY |
| Other net ppe | CurrentQuarterInstant | 19804000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 89060000000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 89742000000 | JPY |
| Goodwill | Prior1YearInstant | 3016000000 | JPY |
| Goodwill | CurrentQuarterInstant | 2624000000 | JPY |
| Other ia | Prior1YearInstant | 4569000000 | JPY |
| Other ia | CurrentQuarterInstant | 4166000000 | JPY |
| Intangible assets | Prior1YearInstant | 7586000000 | JPY |
| Intangible assets | CurrentQuarterInstant | 6790000000 | JPY |
| Investment securities | Prior1YearInstant | 33511000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |